Vector comprising multiple homologous nucleotide sequences
AssigneeBavarian Nordic A/S
InventorRobin Steigerwald
Life of this patent
Estimating the term…
Abstract
The invention relates to vectors comprising two or more homologous nucleotide sequences and methods for generating them. The invention concerns substituting bases in the homologous nucleotide sequences with different bases that do not alter the encoded amino acid sequence. The invention allows for the reduction of intramolecular recombination between homologous nucleotide sequences, in particular in mammalian cells. The invention further relates to nucleotide sequences containing substituted bases.
Claims8
A method for generating a stable modified vaccinia Ankara (MVA) virus vector comprising:
- providing a vector or vectors containing two nucleotide sequences of at least 2000 nucleotides each, wherein each nucleotide sequence encodes a single Ebola virus glycoprotein;
- substituting at least 400 nucleotides in one or both of the nucleotide sequence(s) to generate two divergent sequences;
- wherein the 400 substituted nucleotides do not alter the amino acids encoded by the two divergent sequences;
- and
- generating a stable MVA vector comprising the two divergent sequences stably inserted into the MVA genome,
- wherein the two divergent sequences share stretches of identity of no more than 10 contiguous nucleotides;
- and
- wherein the two nucleotide sequences encode Ebola virus Sudan and Ebola virus Zaire glycoproteins.
A method for generating a stable modified vaccinia Ankara (MVA) virus vector comprising:
- providing two nucleotide sequences of at least 2000 nucleotides each, wherein each nucleotide sequence encodes a single Ebola virus glycoprotein;
- substituting at least 400 nucleotides in one or both of the nucleotide sequence(s) to generate two divergent sequences;
- wherein the 400 substituted nucleotides do not after the amino acids encoded by the two divergent sequences;
- and
- generating a stable MVA vector comprising the two divergent sequences stably inserted into the MVA genome,
- wherein the two divergent sequences share stretches of identity of no more than 10 contiguous nucleotides;
- and
- wherein the two nucleotide sequences encode Ebola virus Sudan and Ebola virus Zaire glycoproteins.
A method for generating a stable modified vaccinia Ankara (MVA) virus vector comprising:
- providing first and second nucleotide sequences of at least 2000 nucleotides each,
- wherein each nucleotide sequence encodes a single Ebola virus glycoprotein,
- wherein one of the two nucleotide sequences is a substituted nucleotide sequence, having at least 400 substituted nucleotides different from the other nucleotide sequence,
- wherein the substituted nucleotides do not alter the amino acids encoded by the first and second nucleotide sequences,
- and wherein the two nucleotide sequences share stretches of identity of no more than 10 contiguous nucleotides;
- and
- inserting the first and second nucleotide sequences into an MVA vector to generate a stable MVA vector,
- wherein the two nucleotide sequences encode Ebola virus Sudan and Ebola virus Zaire glycoproteins.
Dependencies are inferred from the claim text.